Only Medics

Recruiting Physicians for Pharma

Close
  • Vacancies
    • Sectors
      • Medical Advisor Roles
      • Medical Director Roles
      • Medical Affairs
      • Pharmacovigilance Physician
  • Clients
    • Services
    • Interims
    • Enquiries
    • Executive Search
    • Testimonials
  • Candidates
    • Send Us your CV
    • Referral Scheme
    • Services
    • Interim
    • Career Advice
    • Career Enquiries
    • Relocation
    • Testimonials
  • Pharma
    • The Pharma Industry
    • UK Medics
    • UK Training Workshops
  • Resources
    • Brochure and Adverts
    • Downloads
    • Pharmaceutical Terms
    • Links
    • Industry Analytics
  • About Us
    • Clinical Professionals Group
    • Contact
    • Privacy Policy
    • Environment
    • Ethics
  • My Account
Menu

asthma

Written by 56gqy
July 10, 2020

Use of steroid inhalers supported by UK researchers during pandemic

Researchers from Huddersfield University have stated that the benefits of using steroid-containing inhalers and nebulisers during the COVID-19 pandemic outweigh the risks, despite warnings to the contrary. Previously, the WHO advised back in March that steroids used in inhalers and nebulisers, such as those prescribed to people with asthma or COPD, could have a negative

Continue Reading

Written by 56gqy
August 15, 2019

Asthma UK report reveal asthma deaths “highest this decade”

Report from Asthma UK has found that deaths from asthma attacks are the highest they have been in the last decade and increased by more than 33% over the last ten years. By analysing data from the Office for National Statistics (ONS), they revealed that more than 1,400 people died from an asthma attack last

Continue Reading

Written by Kat McCarthy
February 28, 2019

High prescription costs could lead to life threatening asthma attacks

Asthma UK has revealed that those with asthma are rationing their medication due to prescription costs which is causing avoidable asthma attacks and extra hospital admissions. Recent reports by the charity has claimed that more than a million people in England are having to ‘pay to breathe’ and are at risk of having a life-threatening

Continue Reading

Written by Kat McCarthy
May 23, 2017

AstraZeneca drug found to lower oral steroid use for asthma

Patients with severe and uncontrolled asthma found that taking AstraZeneca’s experimental drug benralizumab in a late-stage study either significantly reduced the need or stopped altogether their intake of oral corticosteroids (OCS), the drug was also shown to dramatically cut related hospitalisations.

Continue Reading

Categories

  • Clients
  • Uncategorized
  • News
  • Career Advice
  • Company Info
  • Exhibition/Conference
  • Industry News
  • Only Medics
  • Regulatory Professionals
  • Social Media
  • Print

Tags

AI Alkermes Alzheimer's asthma Biogen Biotech Bloodwise BMJ Boehringer Ingelheim Brexit Cancer Drug Fund Charity Chronic Clients Clinical Professionals Company News Dementia Drugs EMA Gilead Healthcare Heart Disease Ireland medical devices meningitis B MHRA Multiple Sclerosis NCI NHS Novo Nordisk obesity Only Medics Parkinson's Pfizer PHE psoriasis Public Health England Reckitt Benckiser Research Roche Sanofi Seqirus Study Takeda Websites

Like to Talk to a Consultant?

Call or email us directly and find out your next career step:
apply@onlymedics.com or +44 (0)118 9522 799

The Clinical Professionals group of Companies.

Job Alerts

Want personalised Job alerts delivered to you periodically?
Click the link below to register your details:



Job Alerts

Contact Us

My Tweets
© 2023 Only Medics — All Rights Reserved
Facebook Twitter Google LinkedIn
Back to Top
 

Loading Comments...